Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma.
Bajetta E, Di Bartolomeo M, Mariani L, Cassata A, Artale S, Frustaci S, Pinotti G, Bonetti A, Carreca I, Biasco G, Bonaglia L, Marini G, Iannelli A, Cortinovis D, Ferrario E, Beretta E, Lambiase A, Buzzoni R; Italian Trials in Medical Oncology (I.T.M.O.) Group.
Bajetta E, et al. Among authors: frustaci s.
Cancer. 2004 Jan 15;100(2):279-87. doi: 10.1002/cncr.11910.
Cancer. 2004.
PMID: 14716761
Free article.
Clinical Trial.